OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
178855

Hi-Clearance Inc

Medical Equipment, Supplies & DistributionVerified

Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.72, suggesting it can cover its short-term obligations but with limited excess capacity. However, the firm's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Hi-Clearance Inc reports a return on equity (ROE) of 12.08% and a return on assets (ROA) of 7.25%, both of which are strong indicators of efficient capital utilization and asset management. These metrics suggest the company is generating solid returns relative to its equity and asset base, though a direct comparison to industry medians is required to assess relative performance. The company's revenue is concentrated within the healthcare services and equipment segment, with no disclosed geographic diversification in the provided data. This lack of geographic segmentation implies a potential concentration risk, as the firm's performance is closely tied to the regional healthcare market in which it operates. Looking ahead, Hi-Clearance Inc is expected to maintain a stable growth trajectory, with no specific numeric deltas provided for the current or next fiscal year. The company's operating cash flow of TWD 389.5 million and free cash flow of TWD 116.2 million support its ability to fund operations and reinvest in the business. However, the capital expenditure of TWD -139.8 million indicates ongoing investment in infrastructure or equipment, which may impact near-term cash flow flexibility. The risk assessment highlights a medium liquidity risk and a low dilution risk. The firm's low dilution risk is supported by the absence of significant dilution sources in the provided data, and the diluted shares outstanding are equal to the basic shares, indicating no imminent dilution pressure. However, the negative net cash position after debt is a key flag that warrants monitoring. Recent events, including filings and transcripts, are not detailed in the provided data, so no specific recent developments can be cited at this time.

30-day price · 1788-1.00 (-0.7%)
Low$134.50High$136.50Close$135.50As of20 May, 00:00 UTC
Profile
CompanyHi-Clearance Inc
Ticker1788.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Hi-Clearance Inc provides medical equipment, supplies, and distribution services within the healthcare sector.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.72, suggesting it can cover its short-term obligations but with limited excess capacity. However, the firm's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Hi-Clearance Inc reports a return on equity (ROE) of 12.08% and a return on assets (ROA) of 7.25%, both of which are strong indicators of efficient capital utilization and asset management. These metrics suggest the company is generating solid returns relative to its equity and asset base, though a direct comparison to industry medians is required to assess relative performance. The company's revenue is concentrated within the healthcare services and equipment segment, with no disclosed geographic diversification in the provided data. This lack of geographic segmentation implies a potential concentration risk, as the firm's performance is closely tied to the regional healthcare market in which it operates. Looking ahead, Hi-Clearance Inc is expected to maintain a stable growth trajectory, with no specific numeric deltas provided for the current or next fiscal year. The company's operating cash flow of TWD 389.5 million and free cash flow of TWD 116.2 million support its ability to fund operations and reinvest in the business. However, the capital expenditure of TWD -139.8 million indicates ongoing investment in infrastructure or equipment, which may impact near-term cash flow flexibility. The risk assessment highlights a medium liquidity risk and a low dilution risk. The firm's low dilution risk is supported by the absence of significant dilution sources in the provided data, and the diluted shares outstanding are equal to the basic shares, indicating no imminent dilution pressure. However, the negative net cash position after debt is a key flag that warrants monitoring. Recent events, including filings and transcripts, are not detailed in the provided data, so no specific recent developments can be cited at this time.
Key takeaways
  • Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34.
  • The company generates strong returns on equity (12.08%) and assets (7.25%), indicating efficient capital use.
  • The firm's liquidity position is medium, with a current ratio of 1.72 and a negative net cash position after debt.
  • Revenue is concentrated in the healthcare services and equipment segment, with no geographic diversification disclosed.
  • The company is expected to maintain a stable growth trajectory, supported by positive operating and free cash flows.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$4.28B
Gross profit$1.14B
Operating income$422.2M
Net income$368.5M
R&D
SG&A
D&A
SBC
Operating cash flow$389.5M
CapEx-$139.8M
Free cash flow$116.2M
Total assets$5.08B
Total liabilities$2.03B
Total equity$3.05B
Cash & equivalents$89.6M
Long-term debt$1.05B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.05B
Net cash-$958.7M
Current ratio1.7
Debt/Equity0.3
ROA7.2%
ROE12.1%
Cash conversion1.1%
CapEx/Revenue-3.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric1788Activity
Op margin9.9%13.3% medp25 5.9% · p75 13.5%below median
Net margin8.6%8.6% medp25 2.7% · p75 12.7%above median
Gross margin26.7%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-3.3%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity34.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 20:38 UTCJob: e6e814e2